Home › Funds › Squadron Capital Management LLC › CTNM

Squadron Capital Management LLC position in CTNM

CONTINEUM THERAPEUTICS INC · Health Care

Squadron Capital Management LLC reported holding 225,000 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 1.20% of its reported portfolio and ranking #29 among its reported holdings. Squadron Capital Management LLC has disclosed CTNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)225.00K sh
Reported value held$3.02M
Portfolio Weight1.20%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's CTNM position evolved

Squadron Capital Management LLC first disclosed a stake in CTNM in Q2 2026 at 260,000 shares (US$4.3M). Across 2 filings, Squadron Capital Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 225,000 shares valued at US$3.0M — a reduction of -35,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 260.00K $4.26M New
Q3 2026 225.00K $3.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTNM and 13F data

CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$37.8M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTNM

All CTNM fund holders →

FAQ

How long has Squadron Capital Management LLC held CTNM?

Squadron Capital Management LLC has disclosed CTNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Squadron Capital Management LLC's current position in CTNM?

As of Q3 2026, Squadron Capital Management LLC holds 225.00K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $3.02M, representing 1.20% of its reported portfolio and ranking #29.

Has Squadron Capital Management LLC been buying or selling CTNM?

In the latest 13F filing (Q3 2026), Squadron Capital Management LLC reduced its position in CTNM.

Which other funds hold CTNM?

Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.